Illumina, Inc. (NASDAQ: ILMN) and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and investment by Illumina into MyOme. The collaboration and investmen ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, together with Alliance Foundation ...
Hyderabad: The Telangana govt is gunning for transforming Hyderabad from being a pillar of the pharma & biotech sector to the ...
Explore how FAME quantifies the impact of genetic variants on traits, enhancing our understanding of complex genetic ...
Genome & Co. has divulged antibody-drug conjugates consisting of antibodies targeting basal cell adhesion molecules (BCAM) covalently linked to a cytotoxic drug through a linker reported to be useful ...
Arima Genomics, Inc., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced new data to be presented at the ...
Researchers identify distinct genetic loci involved in delay discounting and how these variants are involved in physical and ...
This month Genome Research publishes a special issue highlighting novel advances in computational biology. In collaboration ...
Guwahati: A landmark study by the Tata Memorial Centre (TMC) has identified genetic factors that increase the risk of cancer among Indians, particularly people from the northeast. The research shows ...
“Delay discounting is measurable, highly heritable and relevant to many aspects of health,” Sanchez-Roige added. “By continuing to investigate this fundamental decision-making process, we may uncover ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback